ID   ACC-3
AC   CVCL_6873
SY   Acc-3; ACC3
DR   BioSample; SAMN03151660
DR   Wikidata; Q54608099
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=10359046;
RX   PubMed=19557180;
RX   PubMed=20143388;
RX   PubMed=21868764;
WW   https://iclac.org/wp-content/uploads/Cross-Contaminations_v12_distribution.xlsx
WW   https://web.archive.org/web/20110617125837/http://www.accrf.org/pdf/accrf_update_march2009.pdf
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764). Originally thought to originate from a 49 year old male patient with a salivary gland adenoid cystic carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00358.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 25
//
RX   DOI=10.4103/2468-5585.200513;
RA   Liu N.-N., Zhang S.-L., Chen W.;
RT   "The cross-contaminated cell lines of adenoid cystic carcinoma:
RT   a crucial concern.";
RL   Transl. Surg. 2:10-13(2017).
//
RX   PubMed=10359046; DOI=10.1111/j.1349-7006.1999.tb00749.x;
RA   Toyoshima K.-e., Kimura S., Cheng J., Oda Y., Mori K.J., Saku T.;
RT   "High-molecular-weight fibronectin synthesized by adenoid cystic
RT   carcinoma cells of salivary gland origin.";
RL   Jpn. J. Cancer Res. 90:308-319(1999).
//
RX   PubMed=19557180; DOI=10.1371/journal.pone.0006040;
RA   Phuchareon J., Ohta Y., Woo J.M., Eisele D.W., Tetsu O.;
RT   "Genetic profiling reveals cross-contamination and misidentification
RT   of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS,
RT   ACCS and CAC2.";
RL   PLoS ONE 4:E6040-E6040(2009).
//
RX   PubMed=20143388; DOI=10.1002/ijc.25242;
RA   Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A.,
RA   MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R.,
RA   Freshney R.I.;
RT   "Check your cultures! A list of cross-contaminated or misidentified
RT   cell lines.";
RL   Int. J. Cancer 127:1-8(2010).
//
RX   PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690;
RA   Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C.,
RA   Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G.,
RA   Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N.;
RT   "Assembly and initial characterization of a panel of 85 genomically
RT   validated cell lines from diverse head and neck tumor sites.";
RL   Clin. Cancer Res. 17:7248-7264(2011).
//